← Leaderboards
Patrick Boen
Lyndra Therapeutics, Inc.
$8,679,033
Attributed
$17,358,066
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.7M · FY2019–21$20M$15M$10M$5M$0
'19
'20
'21
Funding mix
By agency
NIH$17,358,066 · 2
By mechanism
UH3$11,699,793 · 1
UG3$5,658,273 · 1
Top collaborators
- Richard Scranton2 shared
Most similar at Lyndra Therapeutics, Inc.
Same institution · by research overlap
- Andrew Martin Bellinger$10,090,927
- Richard Scranton$12,106,230
- Stephen Zale$5,700,018
Others in their field
Other Emerging Leaders on “Drug Delivery Systems”
- Gary Fanger · Rise Therapeutics, Llc$16,281,749
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Richard Scranton · Lyndra Therapeutics, Inc.$12,106,230
- Soumya Rahima Benhabbour · Univ Of North Carolina Chapel Hill$10,947,393
- Leah Johnson · Research Triangle Institute$10,876,154
- Deborah Bunin · Sri International$10,209,148
Research focus
Drug Delivery SystemsGastric RetentionDosage FormsDoseFda ApprovedFormulationAmendmentDirectly Observed TherapyBaseAnimal ModelAlzheimer&AposEvaluationAnimalsFirst-In-HumanClinical CandidateClinical DataClinical DevelopmentClinical MaterialClinical ResearchClinical TrialsCompliance BehaviorBiological AvailabilityCyclic GmpGovernment